Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
MLTX holding history
MoonLake Immunotherapeutics in every 13F filed by Finepoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −435,785−100.0% | Sold out | Holders |
| Q1 2025 | 435,785 | $17.0M | 2.9% | −12,150−2.7% | Reduced | Holders |
| Q4 2024 | 447,935 | $24.3M | 2.8% | +59,100+15.2% | Added | Holders |
| Q3 2024 | 388,835 | $19.6M | 2.4% | 00.0% | Unchanged | Holders |
| Q2 2024 | 388,835 | $17.1M | 4.9% | +27,919+7.7% | Added | Holders |
| Q1 2024 | 360,916 | $18.1M | 4.6% | −534,084−59.7% | Reduced | Holders |
| Q4 2023 | 895,000 | $62.7K | <0.1% | +563,584+170.1% | Added | Holders |
| Q3 2023 | 331,416 | $18.9M | 9.4% | +29,416+9.7% | Added | Holders |
| Q2 2023 | 302,000 | $15.4M | 5.3% | +302,000 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −382,400−100.0% | Sold out | Holders |
| Q3 2021 | 382,400 | $3.77M | 0.6% | +32,400+9.3% | Added | Holders |
| Q2 2021 | 350,000 | $3.62M | 0.7% | +350,000 | New | Holders |